The use of everolimus in the treatment of neurocognitive problems in tuberous sclerosis (TRON): study protocol for a randomised controlled trial
Crossref DOI link:
Update policy: https://0-doi-org.brum.beds.ac.uk/10.1007/SPRINGER_CROSSMARK_POLICY
Davies, D. Mark
de Vries, Petrus J.
Sampson, Julian R.
Funding for this research was provided by:
Novartis Pharmaceuticals UK Limited